Why FITTER is so important   History of FITTER   The Rome Congress   Recommendations   Research

 

The Rome Congress

FITTER at a glance

Highlights

  • 13 members of the Scientific Advisory Board made up of world's leading experts in the field
  • 150 top Diabetes Specialists present from over 54 countries
  • 20 expert speakers
  • 15,000 followers (FITTER website registrants WW)
  • 30 live symposia in parallel in Asia-Pac & Latin America
  • 4,000 connected live on the day
  • Over 20 hours of video content (recorded sessions & interviews)
  • 90 pages of new recommendations including injection techique, infusion & safety
FITTER Scientific Congress at a glance

Feedback

Feedback from congress attendees

What was presented

  • All major studies since last congress 6 years ago
  • Results of largest international medical survey ever carried out with over 13,264 respondents from 42 countries (organised by BD)
  • All major themes in insulin delivery covered & thoroughly debated via Q&A sessions and multiple breakout groups:
    1. Injection
    2. Infusion
    3. Frequent complications (e.g. lipohypertrophy)
    4. Safety (Needlestick Injuries - NSI - and safety engineered-devices)
    5. Disposal of used sharps
    6. Use of imaging technologies (e.g. ultrasound and infrared)
    7. Improving disposables for pumps and artificial pancreas
  • Alignment achieved on New Recommendations & Golden Rules published: Mayo Clinic Proceedings

    FITTER SAB Members

    Who is on the Scientific Advisory Board and what is their role ?

    The FITTER Scientific Advisory Board is composed of 13 international members who are recognised for their expertise in the field of diabetes. Their role is to review recent published data, build the agenda & programme, identify speakers, co-author recommendations and other publications, facilitate workshops and co-ordinate post-FITTER activities.

    List of FITTER SAB Members:

    Click here to show the FITTER SAB Members
    • Profile Pic SAB

      Dr. Bruce W. Bode MD diabetes specialist at Atlanta Diabetes Associates in Georgia (USA) and is also professor of medicine at Emory University. Interested in real-time continuous glucose sensors and is a recognized world expert in pump therapy and its complications.

      [ Read More ... + ]

      Dr. Bode is a diabetes specialist with Atlanta Diabetes Associates in Atlanta, Georgia, and is currently on the faculty of Emory University, as a Clinical Associate Professor in the Department of Medicine. He received his medical degree from Emory University School of Medicine and completed an internship and residency in internal medicine at Emory University Affiliated Hospitals and a fellowship in diabetes with Paul C. Davidson, MD.

      He has a strong affinity for working with children and young adults with diabetes and is considered one of the leading experts in the world on insulin delivery and glucose sensing. He is on the board of directors of the Georgia chapters of the Juvenile Diabetes Research Foundation and the Georgia diabetes camps. He is a past president of the ADA Georgia Affiliate, editor of the ADA’s 2004 edition of Medical Management of Type 1 Diabetes, and a Fellow of the American College of Endocrinology.

      Dr. Bode continues to be very active in investigational research with NIH and most pharmaceutical companies involved in the development of diabetes medication and products including the prevention of type 1 diabetes and the development of the Artificial Pancreas. As a result, many investigational trials are available at Atlanta Diabetes Associates.

      A prolific writer, Dr. Bode has written or contributed to several other books, including Diabetes DEK—How to Control and Manage Diabetes Mellitus and The Insulin Pump Therapy Book: Insights From the Experts. In addition, he has written or co-written 200 articles and abstracts for professional journals such as The New England Journal of Medicine, Lancet, Diabetes, Diabetes Care, Diabetes Technology and Therapeutics, The Journal of New Developments in Clinical Medicine, Diabetes Metabolism Research and Reviews, and Diabetes Spectrum.

    • Profile Pic SAB

      Dr. Anders Frid Senior consultant at the Clinic of Endocrinology, University Hospital SUS, Malmö, Sweden. A true pioneer in injection technique with a Ph.D thesis in Insulin Injection and Absorption. Author of over 50 published papers and investigator in over 20 clinical trials.

      [ Read More ... + ]

      Medical supervisor for the Diabetes Nurse education at University of Malmö Clinic of Endocrinology UniversityHospital SUS in Sweden

      Born 12 april 1951 Graduated from MedicalSchool June 1977 Specialist in Internal Medicine January 1985 Thesis for the degree of Dr. Med. Sc. (Ph D) March 1992 at Karolinska Institute in Stockholm: Insulin Injection and Absorption

      Since October 2001 senior consultant at Clinic of Endocrinology, University Hospital SUS, Malmö, Sweden.

      Investigator in over 20 clinical trials. Certified in GCP. Anders Frid has published over 50 papers mainly in the areas of insulin injection technique, diabetes and pregnancy and diet and diabetes.

    • Profile Pic SAB

      Mr. Giorgio Grassi Senior Physician, Division of Endocrinology at the Ospedaliero-Universitaria San Giovanni Battista di Torino, Italy. Coordinator of the Italian Study Group Technologies for the Treatment of Diabetes and Member of the Italian Study Group on Injection therapy in Diabetes.

      [ Read More ... + ]

      Giorgio Grassi (December 6, 1953 Torino, Italy), Senior Physician Division of Endocrinology A. Ospedaliero-Universitaria San Giovanni Battista di Torino. Main activity with type 1 diabetic patients intensively treated with insulin pump (CSII), telemedicine for home blood glucose monitoring, diabetic pregnancy. Past-Coordinator of the Italian Study Group Technologies for the Treatment of Diabetes (Società Italiana di Dabetologia AMD, Associazione Medici Diabetologi SID, Società Italiana di Endocrinologia Pediatrica SIEDP), Member of the Italian Study Group on Injection therapy in Diabetes.

      Dott. Giorgio Grassi Division of Endocrinology and Metabolism Department of Internal Medicine Citta della Salute e della scienza, C.so Bramante 88, 10126 Torino, Italy

    • Profile Pic SAB

      Mr. Serge Halimi Head Department of Endocrinology Diabetology Nutrition , University Hospital Grenoble, France. Former President of SFD and French Guidelines for the Treatment of Type 2 Diabetes. Former Editor of Diabetes Metabolism (1999 – 2005), La Presse Médicale (2002- 2009).

      [ Read More ... + ]

      Professor Serge Halimi. MD.PhD. Head Dpt Endocrinology Diabetology Nutrition University Hospital Grenoble France

      Background

      • Assistant Professor Geneva Switzerland
      • Past President SFD (French Speaking Association for the Study of Diabetes) 2006 - 2010
      • President of French Guidelines for the Treatment of Type 2 Diabetes(HAS AFSSAPS) 1998 - 2007
      • Coordinator of co-coordinator investigator of trials: Servier international,Roche Dics, MSD, Novartis, Takeda, Bayer Pharma

      Publications

      • 180 Medline / 374 in Research Gate

      Editors

      • Editor in Chief Diabetes Metabolism 1999 - 2005 Elsevier Masson
      • Co-Editor in Chier la Presse Médicale Elsevier Masson 2002 - 2009
      • Founder and Editor in Chief la Médicine Maladies Métaboliques Elsevier Masson 2007 - 2013: Main CME journal for french speaking area on diabetes, complications, metabolic disorders ans obesity, dyslipidemias (France, Belgium, Switzerland, North Africa, sub-Saharan Africa).

      Medical & Scientific Societies Member

      • ADA
      • EASD
      • SFD

      Main topics

      • Type 2 diabetes, therapeutic of type 2 diabetes, oral antidiabetic new drugs, metformin, incretins, SGLT2 inhibitors
      • Hypoglycaemia
      • Diabetic nephropathy
      • Cardiovascular complications
      • Clinical inertia
      • Insulin treatment
      • Therapeutic education
      • Healthcare organization
    • Profile Pic SAB

      Mrs. Debbie Hicks Nurse Consultant – Diabetes. Barnet, Enfield and Haringey Mental Health Trust. Chair of Diabetes Nursing Strategy Group and former Chair National Nurse Consultant Group 2012 – 2014. Editor-in-Chief Journal of Diabetes Nursing. Founder, Co-Chair of TREND UK, Chair of FIT (Forum for Injection Technique) UK and President of FIT International.

      [ Read More ... + ]

      Debbie Hicks, Nurse Consultant – Diabetes Barnet, Enfield and Haringey Mental Health Trust

      Debbie began in diabetes nursing in 1990 where she developed the Diabetes Specialist Nursing Service in Hull from being a lone practitioner to being the lead DSN with seven other DSN colleagues.

      In September 2005 she moved south to take up the post of Nurse Consultant – Diabetes. She leads a team of four nurses and two administrative staff. The role of the Enfield Community Services Diabetes Nursing team is to provide high-quality, patient-centred diabetes care based within the community. Education is provided for both people with diabetes and healthcare professionals, and support practice-based teams to provide structured diabetes care for their patients.

      She has been involved in various national groups, including as the Chair of the Diabetes Nursing Strategy Group. She was Chair of the National Nurse Consultant Group from 2012 – 2014. She was one of the authors of the Consensus Document for Blood Glucose Monitoring in 2005, which is still widely used in the UK today.

      Debbie has published over a hundred and ten papers in the UK, Italy, France and the United States, with sixty as first author, since she began in diabetes nursing in 1990. Topics of publication include insulin therapy, injection device choice, injections, blood glucose monitoring, care delivery, patient education, service redesign and many more. She has presented papers in the UK, Europe, New Zealand, Israel, Switzerland and the Republic of Ireland.

      Debbie has been a member of the editorial board of the Journal of Diabetes Nursing since it was first published in 1996 and included her “Diabetes Issues” problem page. She is now the Editor-in-Chief.

      Debbie is a founding member and Co-Chair of TREND-UK (Training, Research and Education for Nurses in Diabetes-UK) which was launched in January 2010. TREND-UK published the 3rd Edition of An Integrated Career and Competency Framework for Diabetes Nursing in February 2011. She is also the Chair of FIT (Forum for Injection Technique) UK and President of FIT International, which aims to encourage best practice in injection technique for all healthcare professionals and people with diabetes using injectable therapies to ensure optimum benefit from these medications.

      She still finds diabetes nursing challenging, stimulating and highly rewarding even after 25 years.

    • Profile Pic SAB

      Dr. Laurence Hirsch Vice President, Global Medical Affairs, BD Medical, Diabetes Care. A leading medical researcher, publishing numerous research papers on all aspects of insulin injection technique, needle design and insulin absorption. A graduate of Harvard Medical School, he is board-certified in Internal Medicine and in Endocrinology and Metabolism and is a former President of ISMPP (International Society for Medical Publishing Professionals).

      [ Read More ... + ]

      Since 2006, Larry Hirsch is Vice President, Global Medical Affairs for the Diabetes Care business unit at BD (Becton Dickinson). Dr. Hirsch provides medical perspective to the business; he also designs and reports its clinical trials for new product development and post-registration. He has overseen BD’s published studies on the thickness of skin and subcutaneous fat at injection sites, the performance of the world’s first 4mm x 32G insulin pen needle including in obese patients – and the impact of various needle design innovations on insulin absorption, intramuscular injection risk, pain, ease of use, and patient preference. He also provides medical direction to development programs for novel devices and technologies for insulin infusion and delivery at BD. Larry routinely interacts with investigators, academic centers and professional organizations including AACE, ADA, JDRF, EASD, AdvaMed and the IDF for the Diabetes Care business.

      Dr. Hirsch previously spent nearly 18 years at Merck (MSD), where he oversaw clinical outcome studies with Merck’s statins, lovastatin (Mevacor®) and simvastatin (Zocor®), and led the worldwide clinical development of alendronate (Fosamax®) for osteoporosis, presenting the initial NDA to the FDA Advisory Committee in 1995. He also started and led the function for peer-reviewed publications related to Merck’s clinical research, 2001-2006. Larry is a founding member and was the 3rd President of ISMPP (International Society for Medical Publication Professionals), a non-profit professional organization. He has strong interests in issues such as research conduct, authorship, conflicts of interest, editorship and the publication process.

      Outside of work, Larry is an avid golfer, enjoys skiing, home theater, roller coasters, good food, wine and craft beers shared with friends and family, seeing his children doing well, and his golden retrievers (not necessarily in that order).

      Dr. Hirsch is a graduate of HarvardMedicalSchool and is board-certified in Internal Medicine and in Endocrinology and Metabolism, having trained at MichaelReeseHospital and U. of Chicago. He has lived a very active life with type 1 diabetes, taking insulin more than 57 years – Larry is a recipient of the Joslin Clinic’s 50-year Medal.

    • Profile Pic SAB

      Prof. Irl Bennett Hirsch Professor of Medicine, University of Washington (USA) and a research focus on real-time continuous glucose sensors. Interested in the role of glucose variability in the development of diabetic complications. He is a world authority on many aspects of diabetes management and has recently become a strong advocate for optimizing insulin injection technique.

      [ Read More ... + ]

      Irl B. Hirsch, MD, is professor and Diabetes Treatment and Teaching Chair at the University of Washington School of Medicine in Seattle.

      Dr. Hirsch received his medical degree from the University of Missouri School of Medicine in 1984. He completed residency training in internal medicine at Mount Sinai Medical Center in Miami and Miami Beach, Florida. Dr. Hirsch also was fellowship-trained in endocrinology and metabolism at Washington University School of Medicine in St. Louis.

      Dr. Hirsch has dedicated his career to patient care, clinical research and teaching. His focus in these areas is the treatment and management of diabetes. He has an interest in new technologies for the treatment of diabetes, particularly those involved in the use of insulin therapy. This interest centers on the mechanisms of how insulin co-modulates inflammation with glucose and how this results in improved outcomes for patients.

      He has been involved in numerous major clinical research trials, including the DCCT, ACCORD, STAR-1, JDRF Sensor Trial, SEARCH, ORIGIN, ADAG and many more involved with insulin therapy.

      Additionally, he has an interest in the use of computers in diabetes data management, and how pattern recognition can be used to improve diabetes control and how glycemic variability noted on glucose meter downloads may be an independent risk for microvascular complications.

      These ideas have led to the funding and completion of the trial FLAT-SUGAR (FLuctuATion reduction with inSUlin Glp-1 Added togetheR).

      Dr. Hirsch has authored more than 170 research papers, including a review of insulin in the New England Journal of Medicine. He also has written more than 60 editorials, three commentaries for The Journal of the American Medical Association, numerous book chapters and four books for patients and physicians.

      He is the past editor-in-chief of DOC News and Clinical Diabetes and former chair of the Professional Practice Committee for the American Diabetes Association and served as a member of the Endocrine Section of the American Board of Internal Medicine. Currently, he is section editor for Up-To-Date.

      Dr. Hirsch has been honored at every level of his career, including being recognized with the Outstanding Young Physician Award by the University of Missouri Alumni Association in 2001, and in 2003 being honored as the American Diabetes Association’s Physician- Clinician of the Year. In 2005, he received the American Association of Clinical Endocrinologists’ Distinguished Endocrinologist Award, and in 2013, he received the American Diabetes Association’s Josiah K. Lilly Sr. Distinguished Service Award. In April 2015 he was elected to a Mastership by the American College of Physicians.

    • Profile Pic SAB

      Prof. Linong Ji Professor Ji is a chief physician and Head of the Endocrinology Department at Peking University People’s Hospital. He is Vice-President of the International Diabetes Foundation (IDF) and former President of the China Diabetes Society (CDS).

      [ Read More ... + ]
      • Chief physician Professor
      • Head of Endocrinology Department at Peking University People’s Hospital
      • Vice President of International Diabetes Foundation (IDF)
      • Former President of China Diabetes Society (CDS)
    • Profile Pic SAB

      Dr. Sanjay Kalra Dr Sanjay Kalra, DM (AIIMS), is a consultant endocrinologist at Bharti Hospital, Karnal, Haryana, who has worked as Principal Investigator in over 50 phase 1,2, and 3 clinical trials. Executive Editor of Indian Journal of Endocrinology and Metabolism, he serves on the editorial board of other national and international journals. As Vice President of the South Asian Federation of Endocrine Societies (SAFES), he works to strengthen capacity for diabetes and endocrine care across the subcontinent,

      [ Read More ... + ]

      Dr Sanjay Kalra, DM (AIIMS), is a consultant endocrinologist at Bharti Hospital, Karnal, Haryana, who has worked as Principal Investigator in over 50 phase 1,2, and 3 clinical trials. Executive Editor of Indian Journal of Endocrinology and Metabolism, he serves on the editorial board of other national and international journals.

      As Vice President of the South Asian Federation of Endocrine Societies (SAFES), he works to strengthen capacity for diabetes and endocrine care across the subcontinent, and is working hard to achieve South Asian endorsement for FIT India guidelines. Lead author of these guidelines, and has also ensured annual updation of the document.

      Apart from clinical practice, research, and academics, he finds time to indulge in his favourite hobby, the bhangra folk dance.

    • Profile Pic SAB

      Mrs. Gillian Kreugel Nurse Consultant - Diabetes, University Medical Center, Groningen, The Netherlands. International speaker at EADV, FEND, EASD and ADA and principal investigator in two RCTs on pen needle length as well as author of several papers on needle length.

      [ Read More ... + ]

      Gillian Kreugel (1956, Kuala Lumpur) RN, BSN, MSN, works as Nurse Consultant Diabetes, Investigator, and trainer Motivational Interviewing/ Mindfulness (MBSR/MBCT) at the University Medical Center in Groningen, The Netherlands. Since the end of the 20st century Gillian has been dedicated to the challenges of a correct injection technique with insulin. She has given national and international presentations, including the EADV FEND, the EASD and the ADA.

      Gillian was principal investigator in two RCT’s on pen needle length and author of:

      Kreugel G, Beijer HJM, Kerstens MN, Maaten ter JC, Sluiter WJ, Boot BS. Influence of needle size for subcutaneous insulin administration on metabolic control and patient acceptance. European Diabetes Nursing. 2007; 4: 51-4.

      Kreugel G, Keers JC, Kerstens MN, Wolffenbuttel BH. Randomized Trial on the Influence of the Length of Two Insulin Pen Needles on Glycemic Control and Patient Preference in Obese Patients with Diabetes. Diabetes Technol Ther. 2011; 13: 737-41.

      Furthermore, she wrote the chapter Diabetes Mellitus in ‘Effectief Verplegen 3’ (Kavanah 2013, ed. Th. Van Achterberg) a book for nursing students and ‘De meest gestelde vragen over Diabetes en zelfcontrole’ (Bohn Stafleu van Loghum, 2010), a book for patients with diabetes mellitus.

      Gillian’s main motivators are people, people with their stories, concerns and doubts, but also with their passion and dreams.

    • Profile Pic SAB

      Mr. Mike Smith European Clinical Marketing Manager – BD Medical, Diabetes Care. Over 20 years’ experience in diabetes care including as Diabetes Specialist Nurse and Diabetes Network Manager with Plymouth NHS. A key educator in evidence based expert clinical care of injection technique and injection safety, regularly training clinicians across Europe, Middle East and Africa.

      [ Read More ... + ]

      With 20 years’ experience, formally as an Intensive Care Nurse and latterly as Diabetes Specialist Nurse Mike has a wealth of clinical care experience both acute and primary care. For the last 5 years Mike has worked for BD Diabetes Care focussing upon evidence based expert clinical care of injection technique and injection safety.

      Mike has supported a number of clinical associations and bodies across Europe and beyond to produce and publish injection technique and safety clinical recommendations. Mike is closely involved in clinical research and regularly teaches and trains clinicians across Europe, Middle East and Africa on best practice and evidence based clinical solutions for injection technique and safety.

      Mike continues to work closely with expert clinicians helping to design clinical and patient education and support materials with an aim to always deliver clinical solutions that make a difference to healthcare outcomes

    • Profile Pic SAB

      Dr. Kenneth Strauss Global Medical Director, BD Diabetes Care Endocrinologist and Director of Safety in Medicine, European Medical Association

      [ Read More ... + ]

      Education and Professional career

      Ken Strauss is the Global Medical Director for Becton Dickinson, and Director of Safety in Medicine for the European Medical Association, based in Brussels.

      Dr. Strauss received his degree as a doctor from the University of South Carolina, USA. He did an Internal Medicine Internship and Residency at the Wake Forest University, USA. His Endocrinology Fellowship was at the Harvard Medical School and Joslin Diabetes Center. He was later on staff at the Harvard Medical School.

      Dr. Strauss speaks in English, French and Spanish to health care worker (HCW) audiences throughout Europe, Africa and the Middle East on topics related to diabetes, HIV disease and patient safety. As Medical Director he performs research trials at university hospitals throughout Europe and other parts of the world. In addition he develops disease management and educational tools for use in the clinical setting by doctors, nurses and patients. He publishes in peer-reviewed medical journals.

      Scientific interests

      Dr. Strauss’ scientific interests in Immunology has led to publications in HIV disease, cellular activation and natural killer cell function, tumor immunology, HLA-B27-related rheumatologic conditions and screening, transplant cross-matching and graph rejection, pathophysiology of multiple sclerosis, leukemia diagnosis and minimal residual disease, platelet activation in vascular disease and stem cell transplantation in cancer patients.

      As an endocrinologist he has an overriding interest in diabetes. Publications cover the subjects of diabetes management and education, efficacy of insulin injecting devices, safe injection technique, intensive glucose management, GP office management of diabetes and the epidemiology of diabetes in developing regions of Africa and Eastern Europe.

      Additionally, Strauss has published on peripheral and central line catheters, anesthesia and surgical devices, safety injection devices, sharps disposal units, spinal and epidural catheters and vaccination devices.

      Additional interests

      Dr. Strauss does annual volunteer medical work in clinics in Africa and South America. He is a physician/writer who currently lives on the French-Belgian border in a château which he restored and from which he writes. His first novel, La Tendresse, is partially set in the Château du Jardin, near the towns and fields in which its turbulent story takes place. His second novel is titled Maria Lindisima and is a thriller involving a terrorist attack in the form of a pandemic. His third novel, Madness, is the story of a Jewish orphan who not only survives in Nazi Germany, but fights the regime as a member of the Wisse Rose. He is currently working on two other novels.

      More information about Dr. Strauss

      en.wikipedia.org/wiki/Ken_Strauss kenstraussposts.blogspot.com/ la.tendresse.free.fr/

      Professional Interests

      • HIV
      • Diabetes
      • Safe and Effective Injections
      • Clinical trials on medical devices
      • Developing Continuing Medical Education programs for Doctors and Nurses
      • Medical missions in Africa
    • Profile Pic SAB

      Dr. Regine Wellhöner Specialist in Internal Medicine with Diabetology, Endocrinology & Nephrology and former Diabetes Department Red Cross Hospital Kassel, Germany 2008 – 2014. Board Member of Hessische Fachvereinigung für Diabetes (HFD), member of EASD and Deutsche Diabetes Gesellschaft (DDG), with specific interest in lipohypertrophy and injection technique.

      [ Read More ... + ]

      After medical thesis in mitochondrial diabetes (working with Professor Dr. Heiner Laube, Giessen) I was working as a resident physician with Professor Hans-Ulrich Haering. Insulin resistance was my major interest and I was part of the research team of the Tuebingen Family Study. After residency I specialised in endocrinology and diabetes as well as nephrology. Afterwards I worked as senior physician in Red Cross Hospital Kassel as head of the department of diabetes there. Treatment of the diabetic foot became more and more important to me during that time. 2013 I started investigation of lipohypertrophy with ultrasound and got interested in the correct insulin injection technique. 2015 I started my own practice in Kassel with Focus on diabetes.

    Speakers List

    List of FITTER Speakers:

    Click here to show the FITTER Speakers
    • Profile Pic SAB

      Dr. Ronnie Aronson Endocrinologist practicing in Toronto and Executive Director of LMC Diabetes & Endocrinology - 9 Diabetes & Endocrinology Centres of Excellence in Canada. Dr. Aronson has been Principal Investigator in over 280 trials in diabetes and its complications and CV risk factors

      [ Read More ... + ]

      Ronnie Aronson, MD, FRCPC, FACE
      Endocrinology & Metabolism
      Executive Director at LMC Diabetes & Endocrinology

      Dr. Ronnie Aronson is an Endocrinologist, practicing in Toronto, Canada since 1995. He serves as Executive Director of LMC Diabetes & Endocrinology - 9 Diabetes & Endocrinology Centres of Excellence in Ontario, Alberta and Quebec. The clinics provide a nationally-accredited diabetes education program and a practice group of 30 Specialists in Endocrinology & Diabetes, caring for >40,000 active patients.

      Dr. Aronson has been Principal Investigator in over 280 trials in diabetes and its complications and CV risk factors such as obesity, lipid disorders and hypertension.

      LMC is Canada's largest research network in Diabetes and provides Canada's only Phase 1 Diabetes research facility. LMC is also currently ranked #28 as a Best Workplace™ in Canada.

      Dr. Aronson serves as a consultant to several pharmaceutical and device companies in both drug development & marketing, as well as in health care provider education.

    • Profile Pic SAB

      Dr. Bruce W. Bode MD diabetes specialist at Atlanta Diabetes Associates in Georgia (USA) and is also professor of medicine at Emory University. Interested in real-time continuous glucose sensors and is a recognized world expert in pump therapy and its complications.

      [ Read More ... + ]

      Dr. Bode is a diabetes specialist with Atlanta Diabetes Associates in Atlanta, Georgia, and is currently on the faculty of Emory University, as a Clinical Associate Professor in the Department of Medicine. He received his medical degree from Emory University School of Medicine and completed an internship and residency in internal medicine at Emory University Affiliated Hospitals and a fellowship in diabetes with Paul C. Davidson, MD.

      He has a strong affinity for working with children and young adults with diabetes and is considered one of the leading experts in the world on insulin delivery and glucose sensing. He is on the board of directors of the Georgia chapters of the Juvenile Diabetes Research Foundation and the Georgia diabetes camps. He is a past president of the ADA Georgia Affiliate, editor of the ADA’s 2004 edition of Medical Management of Type 1 Diabetes, and a Fellow of the American College of Endocrinology.

      Dr. Bode continues to be very active in investigational research with NIH and most pharmaceutical companies involved in the development of diabetes medication and products including the prevention of type 1 diabetes and the development of the Artificial Pancreas. As a result, many investigational trials are available at Atlanta Diabetes Associates.

      A prolific writer, Dr. Bode has written or contributed to several other books, including Diabetes DEK—How to Control and Manage Diabetes Mellitus and The Insulin Pump Therapy Book: Insights From the Experts. In addition, he has written or co-written 200 articles and abstracts for professional journals such as The New England Journal of Medicine, Lancet, Diabetes, Diabetes Care, Diabetes Technology and Therapeutics, The Journal of New Developments in Clinical Medicine, Diabetes Metabolism Research and Reviews, and Diabetes Spectrum.

    • Profile Pic SAB

      Ms. Kelly Close Kelly Close founded Close Concerns in 2002, a healthcare information company focused exclusively on diabetes and obesity. She is on the editorial board of Clinical Diabetes, a journal focused on diabetes for primary care physicians published quarterly by the ADA and is founder and Editor-in-Chief of diaTribe, founded in 2006 as an educational resource for people with diabetes.

      [ Read More ... + ]

      Kelly Close founded Close Concerns in 2002, a healthcare information company focused exclusively on diabetes and obesity. At Close Concerns, Kelly and her team write approximately five million words each year on diabetes, obesity, and digital health. Kelly's passion for the field comes from her extensive professional work as well as from her personal experience, having had diabetes for nearly 30 years. Kelly is the co-author of over 20 peer-reviewed manuscripts as well as “Targeting A Cure for Type 1 Diabetes: How Long Do We Have to Wait?” a widely-praised book published by the ADA in 2013. Kelly is on the editorial board of Clinical Diabetes, a journal focused on diabetes for primary care physicians published quarterly by the ADA. Close Concerns won the ADA’s “Excellence in Health Communications” Award in 2012 and Kelly and her team write a quarterly column in Journal of Diabetes, a peer-reviewed journal based in Shanghai.

      Kelly is founder and Editor-in-Chief of diaTribe, founded in 2006 as an educational resource for people with diabetes. She also chairs The diaTribe Foundation, a nonprofit established in 2012 to improve the lives of people with diabetes and pre-diabetes and to advocate for action. Well over 1 million individuals have visited diaTribe.org in the past year. Before starting Close Concerns and the diaTribe Foundation, Kelly’s work focused on life sciences more broadly. Over nearly a dozen years, she worked on Wall Street and at McKinsey & Company, where her work centered on pharmaceutical, managed care, and nonprofit organizations.

      Kelly has a BA in Economics and English from Amherst College and an MBA from Harvard Business School. She was a founding board member of the Institute for Responsible Nutrition, led by Dr. Robert Lustig, and a previous executive board member of the Diabetes Hands Foundation and the Behavioral Diabetes Institute. She and husband John are co-hosts of the popular discussion series CPS Lectures. They live in San Francisco with their three children.

    • Profile Pic SAB

      Dr. Dorothee Deiss Dorothee Deiss, MD has extensive expertise in continuous glucose monitoring and insulin delivery devices. She is currently working as a pediatric, adult and gestational diabetologist and endocrinologist in Berlin

      [ Read More ... + ]

      Pediatric, Adult and Gestational Diabetology and Endocrinology Endokrinologikum Berlin, Germany

      Dorothee Deiss, MD has extensive expertise in continuous glucose monitoring and insulin delivery devices. Dr. Deiss is currently working as a pediatric, adult and gestational diabetologist and endocrinologist in Berlin.

      She is a member of several steering commitees, advisory boards, and international diabetes associations.

      Dr. Deiss is the author of numerous publications in the field of diabetes technology.

      While at the University Children's Hospital Charité in Berlin, Dr. Deiss introduced the continuous glucose monitoring system for pediatric use and real-time CGM in Germany.

      She investigated and evaluated hypoglycaemia, glycemic control and treatment modalities in patients with type-1 diabetes and in patients with glycemic disorders, hyperinsulinism, Dumping syndrome, MODY and pediatric type-2 diabetes.

      As a member of the research team of Prof. Bruce Buckingham she studied closed loop algorithms at Stanford University CA.

    • Profile Pic SAB

      Dr. Pascal Fascia Dr. Fascia is an infectious diseases specialist and epidemiologist. Pascal Fascia is Head of Rhône-Alpes Regional Office for the Prevention of Health-care Associated Infections, University Hospital of Lyon, France

      [ Read More ... + ]

      Dr. Fascia graduated from the Faculty of Medicine of Lyon (France) and was trained in epidemiology and public health in 2000. After a Master 1 in Biostatistics and a Master 2 in Clinical Research on evaluation methods of health interventions, he completed his training by specializing in infectious diseases.

      His professional activity is focused on preventing infection risk and nosocomial infection risk, while continuing clinical activity as a consultant in the infectious disease department of the University Hospital of Saint-Etienne (France) until 2012.

      During these years of practice in the prevention of nosocomial infections, Dr. Fascia has led several studies including one on infection risk factors in the use of invasive devices such as hypodermoclysis.

      After 12 years in the hygiene team of the University Hospital of Saint-Etienne (France), Dr. Fascia took up office in the Rhône-Alpes regional office for the prevention of healthcare associated infections. He is coordinating the regional office since August 2014.

      Dr. Fascia and his team’s mission are to organize the prevention of healthcare associated infections in the Rhône-Alpes region of France to all health institutions and long term care (nursing home for the elderly dependents, management of institutions of physical or mental disabilities), independent health care professionals and health professional training institutes.

    • Profile Pic SAB

      Prof. Thomas A. Forst Thomas A. Forst is professor of Internal Medicine at University Mainz and a diabetologist and Endocrinologist.

      [ Read More ... + ]

      Professor Thomas A. Forst
      Professor Internal Medicine University Mainz
      Diabetologist / Endocrinologist
      CEO Profil Mainz GmbH

      Professor Thomas A. Forst is an endocrinologist and diabetologist. From 2001-2013 he was the Medical Director of ikfe GmbH in Mainz and since March 2013 up to now he is the CEO of Profil Mainz GmbH & Co KG, Mainz and responsible for Clinical Research, focused on diabetes mellitus and cardiovascular disease.

      He started his postdoctoral clinical research work at the German Diabetes Research Institute at the Heinrich Heine University in Düsseldorf and completed his residency in Internal Medicine and Endocrinology at the Department of Endocrinology at the Johannes Gutenberg University in Mainz. Since 2001 he is teaching as a Professor for Internal Medicine and Endocinology of the Johannes Gutenberg University in Mainz.

    • Profile Pic SAB

      Dr. Anders Frid Senior consultant at the Clinic of Endocrinology, University Hospital SUS, Malmö, Sweden. A true pioneer in injection technique with a Ph.D thesis in Insulin Injection and Absorption. Author of over 50 published papers and investigator in over 20 clinical trials.

      [ Read More ... + ]

      Medical supervisor for the Diabetes Nurse education at University of Malmö Clinic of Endocrinology UniversityHospital SUS in Sweden

      Born 12 april 1951 Graduated from MedicalSchool June 1977 Specialist in Internal Medicine January 1985 Thesis for the degree of Dr. Med. Sc. (Ph D) March 1992 at Karolinska Institute in Stockholm: Insulin Injection and Absorption

      Since October 2001 senior consultant at Clinic of Endocrinology, University Hospital SUS, Malmö, Sweden.

      Investigator in over 20 clinical trials. Certified in GCP. Anders Frid has published over 50 papers mainly in the areas of insulin injection technique, diabetes and pregnancy and diet and diabetes.

    • Profile Pic SAB

      Mr. Ragnar Hanås Head of the diabetes unit and Consultant in Pediatric Diabetology and Endocrinology at the NU Hospital Group, Uddevalla Hospital, Sweden, and Associate Professor at the Sahlgrenska Academy of Gothenburg’s University, Sweden.

      [ Read More ... + ]

      Ragnar Hanas is head of the diabetes unit and Consultant in Pediatric Diabetology and Endocrinology at the NU Hospital Group, Uddevalla Hospital, Sweden, and Associate Professor at the Sahlgrenska Academy of Gothenburg’s University, Sweden. He has co-authored the Swedish National Pediatric Diabetes Guidelines, and has organized national insulin pump courses since 1999. He did his PhD on injection pain and indwelling catheters in children 2001. He is the author of a comprehensive pediatric diabetes manual, translated into 13 languages, and is a member of Editorial Board of Pediatric Diabetes since 2002. His main research interests are intensive insulin therapy, ketoacidosis, insulin pumps, continuous glucose measuring, injection pain, indwelling catheters and father´s role in diabetes care. He has been investigator in several international trials (ENDIT, TRIGR, PedPumps, Diamyd, TEENS). He was a major contributor to the ESPE/LWPES DKA Consensus 2003, and the ESPE/LWPES/ISPAD Pump Consensus 2007.

      Ragnar Hanas was one of the co-editors of the International Society for Pediatric and Adolescent Diabetes (ISPAD) 2009 Clinical Practice Consensus Guidelines and was head co-author of the 2011 IDF/ISPAD Guidelines. He is the coordinating editor of the 2014 ISPAD Guidelines. He has co-organized ISPAD Postgraduate Courses in Chile, Argentina, Peru, Bolivia, Jamaica and India. He was Secretary General of ISPAD 2008-2012, co-president of the 2013 ISPAD Annual Meeting in Gothenburg, and is the current President of ISPAD.

    • Profile Pic SAB

      Mrs. Debbie Hicks Nurse Consultant – Diabetes. Barnet, Enfield and Haringey Mental Health Trust. Chair of Diabetes Nursing Strategy Group and former Chair National Nurse Consultant Group 2012 – 2014. Editor-in-Chief Journal of Diabetes Nursing. Founder, Co-Chair of TREND UK, Chair of FIT (Forum for Injection Technique) UK and President of FIT International.

      [ Read More ... + ]

      Debbie Hicks, Nurse Consultant – Diabetes Barnet, Enfield and Haringey Mental Health Trust

      Debbie began in diabetes nursing in 1990 where she developed the Diabetes Specialist Nursing Service in Hull from being a lone practitioner to being the lead DSN with seven other DSN colleagues.

      In September 2005 she moved south to take up the post of Nurse Consultant – Diabetes. She leads a team of four nurses and two administrative staff. The role of the Enfield Community Services Diabetes Nursing team is to provide high-quality, patient-centred diabetes care based within the community. Education is provided for both people with diabetes and healthcare professionals, and support practice-based teams to provide structured diabetes care for their patients.

      She has been involved in various national groups, including as the Chair of the Diabetes Nursing Strategy Group. She was Chair of the National Nurse Consultant Group from 2012 – 2014. She was one of the authors of the Consensus Document for Blood Glucose Monitoring in 2005, which is still widely used in the UK today.

      Debbie has published over a hundred and ten papers in the UK, Italy, France and the United States, with sixty as first author, since she began in diabetes nursing in 1990. Topics of publication include insulin therapy, injection device choice, injections, blood glucose monitoring, care delivery, patient education, service redesign and many more. She has presented papers in the UK, Europe, New Zealand, Israel, Switzerland and the Republic of Ireland.

      Debbie has been a member of the editorial board of the Journal of Diabetes Nursing since it was first published in 1996 and included her “Diabetes Issues” problem page. She is now the Editor-in-Chief.

      Debbie is a founding member and Co-Chair of TREND-UK (Training, Research and Education for Nurses in Diabetes-UK) which was launched in January 2010. TREND-UK published the 3rd Edition of An Integrated Career and Competency Framework for Diabetes Nursing in February 2011. She is also the Chair of FIT (Forum for Injection Technique) UK and President of FIT International, which aims to encourage best practice in injection technique for all healthcare professionals and people with diabetes using injectable therapies to ensure optimum benefit from these medications.

      She still finds diabetes nursing challenging, stimulating and highly rewarding even after 25 years.

    • Profile Pic SAB

      Dr. Laurence Hirsch Vice President, Global Medical Affairs, BD Medical, Diabetes Care. A leading medical researcher, publishing numerous research papers on all aspects of insulin injection technique, needle design and insulin absorption. A graduate of Harvard Medical School, he is board-certified in Internal Medicine and in Endocrinology and Metabolism and is a former President of ISMPP (International Society for Medical Publishing Professionals).

      [ Read More ... + ]

      Since 2006, Larry Hirsch is Vice President, Global Medical Affairs for the Diabetes Care business unit at BD (Becton Dickinson). Dr. Hirsch provides medical perspective to the business; he also designs and reports its clinical trials for new product development and post-registration. He has overseen BD’s published studies on the thickness of skin and subcutaneous fat at injection sites, the performance of the world’s first 4mm x 32G insulin pen needle including in obese patients – and the impact of various needle design innovations on insulin absorption, intramuscular injection risk, pain, ease of use, and patient preference. He also provides medical direction to development programs for novel devices and technologies for insulin infusion and delivery at BD. Larry routinely interacts with investigators, academic centers and professional organizations including AACE, ADA, JDRF, EASD, AdvaMed and the IDF for the Diabetes Care business.

      Dr. Hirsch previously spent nearly 18 years at Merck (MSD), where he oversaw clinical outcome studies with Merck’s statins, lovastatin (Mevacor®) and simvastatin (Zocor®), and led the worldwide clinical development of alendronate (Fosamax®) for osteoporosis, presenting the initial NDA to the FDA Advisory Committee in 1995. He also started and led the function for peer-reviewed publications related to Merck’s clinical research, 2001-2006. Larry is a founding member and was the 3rd President of ISMPP (International Society for Medical Publication Professionals), a non-profit professional organization. He has strong interests in issues such as research conduct, authorship, conflicts of interest, editorship and the publication process.

      Outside of work, Larry is an avid golfer, enjoys skiing, home theater, roller coasters, good food, wine and craft beers shared with friends and family, seeing his children doing well, and his golden retrievers (not necessarily in that order).

      Dr. Hirsch is a graduate of HarvardMedicalSchool and is board-certified in Internal Medicine and in Endocrinology and Metabolism, having trained at MichaelReeseHospital and U. of Chicago. He has lived a very active life with type 1 diabetes, taking insulin more than 57 years – Larry is a recipient of the Joslin Clinic’s 50-year Medal.

    • Profile Pic SAB

      Prof. Irl Bennett Hirsch Professor of Medicine, University of Washington (USA) and a research focus on real-time continuous glucose sensors. Interested in the role of glucose variability in the development of diabetic complications. He is a world authority on many aspects of diabetes management and has recently become a strong advocate for optimizing insulin injection technique.

      [ Read More ... + ]

      Irl B. Hirsch, MD, is professor and Diabetes Treatment and Teaching Chair at the University of Washington School of Medicine in Seattle.

      Dr. Hirsch received his medical degree from the University of Missouri School of Medicine in 1984. He completed residency training in internal medicine at Mount Sinai Medical Center in Miami and Miami Beach, Florida. Dr. Hirsch also was fellowship-trained in endocrinology and metabolism at Washington University School of Medicine in St. Louis.

      Dr. Hirsch has dedicated his career to patient care, clinical research and teaching. His focus in these areas is the treatment and management of diabetes. He has an interest in new technologies for the treatment of diabetes, particularly those involved in the use of insulin therapy. This interest centers on the mechanisms of how insulin co-modulates inflammation with glucose and how this results in improved outcomes for patients.

      He has been involved in numerous major clinical research trials, including the DCCT, ACCORD, STAR-1, JDRF Sensor Trial, SEARCH, ORIGIN, ADAG and many more involved with insulin therapy.

      Additionally, he has an interest in the use of computers in diabetes data management, and how pattern recognition can be used to improve diabetes control and how glycemic variability noted on glucose meter downloads may be an independent risk for microvascular complications.

      These ideas have led to the funding and completion of the trial FLAT-SUGAR (FLuctuATion reduction with inSUlin Glp-1 Added togetheR).

      Dr. Hirsch has authored more than 170 research papers, including a review of insulin in the New England Journal of Medicine. He also has written more than 60 editorials, three commentaries for The Journal of the American Medical Association, numerous book chapters and four books for patients and physicians.

      He is the past editor-in-chief of DOC News and Clinical Diabetes and former chair of the Professional Practice Committee for the American Diabetes Association and served as a member of the Endocrine Section of the American Board of Internal Medicine. Currently, he is section editor for Up-To-Date.

      Dr. Hirsch has been honored at every level of his career, including being recognized with the Outstanding Young Physician Award by the University of Missouri Alumni Association in 2001, and in 2003 being honored as the American Diabetes Association’s Physician- Clinician of the Year. In 2005, he received the American Association of Clinical Endocrinologists’ Distinguished Endocrinologist Award, and in 2013, he received the American Diabetes Association’s Josiah K. Lilly Sr. Distinguished Service Award. In April 2015 he was elected to a Mastership by the American College of Physicians.

    • Profile Pic SAB

      Prof. Paul Hofman Professor Hofman is an endocrinologist/diabetologist at the Liggins Institute, University of Auckland. He has been involved in clinical research for 22 years and published over 140 papers.

      [ Read More ... + ]

      Professor Paul Hofman
      Liggins Institute
      University of Auckland

      Professor Hofman is an endocrinologist/ diabetologist at the Liggins Institute, University of Auckland. He has been involved in clinical research for 22 years and published over 140 papers.
      He is actively involved in clinical work at Starship Children's Hospital and assists numerous support groups including the Turner Syndrome society, the CAH society and the Prader Willi Society where he is a past president. He is the immediate past president of the Australasian Paediatric Endocrine Group and is the President of the Asia Pacific Paediatric Endocrine Society.
      He is part of a small group of regional endocrinologists improving endocrine training in the Asia Pacific Region and is involved in teaching at several regional endocrine fellow conferences annually. He is also on several national committees including the Growth Hormone Committee and the National New Born Advisory Board.

      Current Position

      Professor of Paediatric Endocrinology with a joint appointment at the Liggins Institute, University of Auckland and Starship Children's Hospital, Auckland, New Zealand.

      Other positions

      Director of the Paykel Clinical Research Center, Liggins Institute
      Current president of the Asia Pacific Paediatric Endocrine Society
      Member of the National Newborn Screening Advisory Board

      Education

      Trained in Medicine at Auckland Medical School and went on to become a Fellow of the Royal College of Physicians (FRACP, Paediatrics) in 1993. Completed a fellowship in Pediatric Endocrinology at Riley Hospital for Children, Indianapolis 1995-1997 (mentors Scott Rivkees and Ora Pescovitz) before returning to work in New Zealand.

      Non-Scientific Clinical Interests

      Supports several patient/family led groups including groups Diabetes Youth Auckland, NZ Turner Syndrome society, the NZ Congenital Adrenal Hyperplasia society and the NZ Prader Willi Syndrome Society, where he is a past president.

      Training/ Education

      Paul Hofman is part of a small group of regional endocrinologists involved in improving endocrine training in the Asia Pacific Region and regularly is involved in endocrine training workshops in Asia.

      National Governmental Organisations

      Prof. Hofman is member of several national committees including the Growth Hormone Committee and the National New Born Advisory Board.

      Current Research

      This is primarily in four main domains:

      • developmental origins of adult disease
      • diabetes
      • new born screening
      • bone fragility disorders

      In previous papers Prof. Hofman demonstrated insulin resistance occurs following low birth weight (Journal of Clinical Endocrinology and Metabolism 82: 402-406;1997) and being born preterm (New England Journal of Medicine 18; 351(21) :2179-86; 2004). He has extended these observations into older adult cohorts and shown a marked increase in adiposity in mid adult life in preterm as well as evidence for effects on the next generation (Diabetes 2012;61:2479-2483 and PLoS One, 8 (11), e81840. doi:10.1371/journal.pone.0081840).

      He is currently investigating the intergenerational effects of maternal antenatal steroids and the effect of antenatal exercise in over weight and obese mothers to potentially improve maternal outcomes and reduce the risk of later childhood obesity in the offspring.

      Prof. Hofman has been involved in a number of diabetes studies with a recent focus of the effects of diabetes of cardiovascular function in diabetic adolescents and is completing an exercise intervention to examine the improvements in cardiovascular function (Diabetologia 51(7):1317-20;2008, Diabetes Care 2012;35: 2089-2094, Diabetes Care Published Ahead of Print, published online February 26, 2014).

      Most recently he is involved as the primary investigator or collaborator on a number of research studies involved in bone and muscle function including the effects of vibration therapy in cerebral palsy and bisphosphonate therapy in avascular necrosis.

    • Profile Pic SAB

      Dr. Sanjay Kalra Dr Sanjay Kalra, DM (AIIMS), is a consultant endocrinologist at Bharti Hospital, Karnal, Haryana, who has worked as Principal Investigator in over 50 phase 1,2, and 3 clinical trials. Executive Editor of Indian Journal of Endocrinology and Metabolism, he serves on the editorial board of other national and international journals. As Vice President of the South Asian Federation of Endocrine Societies (SAFES), he works to strengthen capacity for diabetes and endocrine care across the subcontinent,

      [ Read More ... + ]

      Dr Sanjay Kalra, DM (AIIMS), is a consultant endocrinologist at Bharti Hospital, Karnal, Haryana, who has worked as Principal Investigator in over 50 phase 1,2, and 3 clinical trials. Executive Editor of Indian Journal of Endocrinology and Metabolism, he serves on the editorial board of other national and international journals.

      As Vice President of the South Asian Federation of Endocrine Societies (SAFES), he works to strengthen capacity for diabetes and endocrine care across the subcontinent, and is working hard to achieve South Asian endorsement for FIT India guidelines. Lead author of these guidelines, and has also ensured annual updation of the document.

      Apart from clinical practice, research, and academics, he finds time to indulge in his favourite hobby, the bhangra folk dance.

    • Profile Pic SAB

      Prof. Linong Ji Professor Ji is a chief physician and Head of the Endocrinology Department at Peking University People’s Hospital. He is Vice-President of the International Diabetes Foundation (IDF) and former President of the China Diabetes Society (CDS).

      [ Read More ... + ]
      • Chief physician Professor
      • Head of Endocrinology Department at Peking University People’s Hospital
      • Vice President of International Diabetes Foundation (IDF)
      • Former President of China Diabetes Society (CDS)
    • Profile Pic SAB

      Dr. Ronald Pettis Director of Parenteral Sciences and a Principal Scientist at BD Technologies, the BD corporate R&D center, and is co-Director for the BD Translational Sciences Center of Excellence.

      [ Read More ... + ]

      Dr. Ronald Pettis is currently the Director of Parenteral Sciences and a Principal Scientist at BD Technologies in Research Triangle Park, NC, the corporate R&D center for BD (Becton Dickinson), and is also a co-Director for the recently created BD Translational Sciences Center of Excellence. He has over 24 years of successful development experience in parenteral drug delivery systems and pharmaceutical formulations, pre-clinical pharmacology testing, first-in-man clinical trials, and biological, protein and analytical chemistry. In his 18 year tenure with BD he has led numerous partnerships with pharma companies, national disease advocacy organizations, and academic and clinical research groups; has designed and performed numerous translational human clinical trials for device feasibility and efficacy; and has successfully transferred numerous technology concepts through product launch including the first commercial microneedle vaccine delivery system, the shortest and finest insulin pen needles currently marketed, and upcoming new subcutaneous infusion sets for insulin infusion.

      Dr. Pettis currently leads a multi-disciplinary team composed of senior level engineering, research, and clinical personnel across multiple project areas including diabetes therapy, new drug delivery system development, and clinical feasibility evaluation. He has been honored twice with BD’s highest award for technical achievement, is the holder of 27 issued US patents, 69 published patent applications, and multiple journal articles in the field of drug delivery. He received his BS in chemistry from the Georgia Institute of Technology, and MS and PhD in Chemistry from the University of NC at Chapel Hill.

    • Profile Pic SAB

      Dr. Augusto Pimazoni-Netto Coordinator of the Diabetes Education and Control Group, Kidney Hospital, Federal University of São Paulo

      [ Read More ... + ]

      Augusto Pimazoni-Netto, MD, PhD, is the Coordinator of the Diabetes Education and Control Group, Kidney Hospital, Federal University of São Paulo, Brazil, an interdisciplinary group of 25 volunteers dedicated to delivering the best education and care to poorly controlled diabetes patients from the public health sector.

      He graduated from the University of São Paulo and completed a three year medical residency at The Brookdale University Hospital and Medical Center, in Brooklyn, New York, USA. He was a consultant for the United Nations Educational, Scientific and Cultural Organization (UNESCO) and for the Division of Chronic Non-Communicable Diseases of the Brazilian Ministry of Health. He was a member of the National Health Council of the Brazilian Ministry of Health. For the past 30 years, Dr Pimazoni-Netto has dedicated his professional life to the planning, implementation and management of projects in the area of diabetes education and control.

    • Profile Pic SAB

      Mr. Mike Smith European Clinical Marketing Manager – BD Medical, Diabetes Care. Over 20 years’ experience in diabetes care including as Diabetes Specialist Nurse and Diabetes Network Manager with Plymouth NHS. A key educator in evidence based expert clinical care of injection technique and injection safety, regularly training clinicians across Europe, Middle East and Africa.

      [ Read More ... + ]

      With 20 years’ experience, formally as an Intensive Care Nurse and latterly as Diabetes Specialist Nurse Mike has a wealth of clinical care experience both acute and primary care. For the last 5 years Mike has worked for BD Diabetes Care focussing upon evidence based expert clinical care of injection technique and injection safety.

      Mike has supported a number of clinical associations and bodies across Europe and beyond to produce and publish injection technique and safety clinical recommendations. Mike is closely involved in clinical research and regularly teaches and trains clinicians across Europe, Middle East and Africa on best practice and evidence based clinical solutions for injection technique and safety.

      Mike continues to work closely with expert clinicians helping to design clinical and patient education and support materials with an aim to always deliver clinical solutions that make a difference to healthcare outcomes

    • Profile Pic SAB

      Dr. Kenneth Strauss Global Medical Director, BD Diabetes Care Endocrinologist and Director of Safety in Medicine, European Medical Association

      [ Read More ... + ]

      Education and Professional career

      Ken Strauss is the Global Medical Director for Becton Dickinson, and Director of Safety in Medicine for the European Medical Association, based in Brussels.

      Dr. Strauss received his degree as a doctor from the University of South Carolina, USA. He did an Internal Medicine Internship and Residency at the Wake Forest University, USA. His Endocrinology Fellowship was at the Harvard Medical School and Joslin Diabetes Center. He was later on staff at the Harvard Medical School.

      Dr. Strauss speaks in English, French and Spanish to health care worker (HCW) audiences throughout Europe, Africa and the Middle East on topics related to diabetes, HIV disease and patient safety. As Medical Director he performs research trials at university hospitals throughout Europe and other parts of the world. In addition he develops disease management and educational tools for use in the clinical setting by doctors, nurses and patients. He publishes in peer-reviewed medical journals.

      Scientific interests

      Dr. Strauss’ scientific interests in Immunology has led to publications in HIV disease, cellular activation and natural killer cell function, tumor immunology, HLA-B27-related rheumatologic conditions and screening, transplant cross-matching and graph rejection, pathophysiology of multiple sclerosis, leukemia diagnosis and minimal residual disease, platelet activation in vascular disease and stem cell transplantation in cancer patients.

      As an endocrinologist he has an overriding interest in diabetes. Publications cover the subjects of diabetes management and education, efficacy of insulin injecting devices, safe injection technique, intensive glucose management, GP office management of diabetes and the epidemiology of diabetes in developing regions of Africa and Eastern Europe.

      Additionally, Strauss has published on peripheral and central line catheters, anesthesia and surgical devices, safety injection devices, sharps disposal units, spinal and epidural catheters and vaccination devices.

      Additional interests

      Dr. Strauss does annual volunteer medical work in clinics in Africa and South America. He is a physician/writer who currently lives on the French-Belgian border in a château which he restored and from which he writes. His first novel, La Tendresse, is partially set in the Château du Jardin, near the towns and fields in which its turbulent story takes place. His second novel is titled Maria Lindisima and is a thriller involving a terrorist attack in the form of a pandemic. His third novel, Madness, is the story of a Jewish orphan who not only survives in Nazi Germany, but fights the regime as a member of the Wisse Rose. He is currently working on two other novels.

      More information about Dr. Strauss

      en.wikipedia.org/wiki/Ken_Strauss kenstraussposts.blogspot.com/ la.tendresse.free.fr/

      Professional Interests

      • HIV
      • Diabetes
      • Safe and Effective Injections
      • Clinical trials on medical devices
      • Developing Continuing Medical Education programs for Doctors and Nurses
      • Medical missions in Africa
    • Profile Pic SAB

      Mrs. Grace Vanterpool MBE Grace is a Consultant Nurse Diabetes with 37 years of experience in the field of Diabetes Care. Currently she leads Diabetes Integrated Care Ealing which is part of the London Northwest Hospitals NHS trust

      [ Read More ... + ]

      Grace has been nursing for 37 years. She specialized very early on in her career, working as a diabetes specialist nurse for 19 years and a consultant nurse in diabetes for 10 years. She works across many sectors primary intermediate and in secondary care.
      Grace currently leads Diabetes Integrated Care Ealing which is part of the largest hospital and community trust in the UK known as London Northwest Hospitals NHS trust which was formed in October 2014. She has published her work in many journals and holds lectureships at two universities.

      Grace has received several awards for her services to diabetes, nursing and ethnic minorities including the NHS and Kings Fund Champions Award Services to diabetes patients in 2003, the Chief Executive Award (Thames Valley) for work done over and above the call of duty in 2004, the Community Nurse of the Year in 2005 and in 2006 she was awarded the Nurse of the Year and was honoured by the Queen when she received an MBE.

      Grace chairs the RCN diabetes forum. She is member of the all parliamentary group for diabetes and sits on the Diabetes Think Tank Group leadby the National Director for diabetes.
      Grace is co-chair of the education task and finish group at Diabetes UK. She has been recognized in the HSJ BME awards in 2013 as being one of the 50 most influential BME leaders in the NHS.

      Grace is a trustee of 3 charities:

      • The Oxford Health Alliance
      • Foundations
      • The African Diabetes Foundation which she set up in 2012
    • Profile Pic SAB

      Dr. Guo Xiaohui Chief Physician, Professor, PhD Supervisor Director of Endocrinology, Peking University First Hospital

      [ Read More ... + ]

      Vice President of Chinese Medical Association Beijing Endocrinology Branch. Standing member of the Eighth Board of Chinese Medical Association Endocrine Society. Standing member of CDS, leader of the Study group of diabetes care and education. Editorial board member and invited reviewer of ’Chinese Journal of Endocrinology and Metabolism’, ‘Chinese Journal of Diabetes Mellitus’, ‘Chinese Journal of Organ Transplantation’, ‘Journal of Diabetes and its Complications’ and ‘Metabolism’.

    • Profile Pic SAB

      Dr. Phyllis Wolff Diabetes nurse practitioner, Florida Health Care Plans.

      [ Read More ... + ]

      Phyllis Wolff,DNP,ARNP-C, a diabetes nurse practitioner, is currently practicing at Florida Health Care Plans in Northeast Florida. Originally from Long Island, New York, she has over 30 years of experience providing individuals with expert diagnosis and management of diabetes: type 1, type 2, gestational, pregnancy in pre-existing diabetes, and cystic fibrosis related diabetes. She has expertise in the management of insulin pumps and continuous glucose monitoring systems. She became a Doctor of Nursing Practice, earning her doctorate at Robert Morris University in 2009. Dr. Wolff has been an invited speaker at multiple diabetes conferences on the US national level. Her published research on the use of insulin pumps in poorly controlled type 2 diabetes has been referenced by other researchers attempting to provide cost effective care for this population while improving outcomes.

    • Profile Pic SAB

      Mr. Jean-Pierre Le Floch Diabetologist, La Clinique de Villecresnes, Villecresnes, France

      [ Read More ... + ]

      J.P. LE FLOCH is a French diabetologist, working in the Villecresnes clinic. His areas of interest deal with the complications of diabetes, especially taste and smell disorders and the diabetes in the elder patients (GERODIAB study). He worked on glucose variability, on complications associated with insulin injections (risk of contamination) and on lipodystrophies.

    • Profile Pic SAB

      Mr. Michael Gibney Associate Director Medical Affairs at BD

      [ Read More ... + ]

      Michael Gibney has been a Registered Nurse for 35 years with more than 30 years working in diabetes care. He is currently working at BD as the Associate Director Medical Affairs with a focus on clinical trials. He also has been living with type 1 diabetes since the age of 25 and uses an insulin pump

    • Profile Pic SAB

      Ms. Susan Guzman Clinical psychologist specializing in diabetes

      [ Read More ... + ]

      Susan Guzman, PhD is a clinical psychologist specializing in diabetes. Her clinical and research focus areas include overcoming barriers to good management, family issues, and promoting attitudes that support living well with diabetes, from diagnosis throughout life. Dr. Guzman integrates empathy, acceptance and practical guidance to help people better utilize their strengths in living life with diabetes.

      In 2003, Dr. Guzman co-founded the Behavioral Diabetes Institute (BDI), the first non-profit organization devoted to the emotional and behavioral aspects of living with diabetes. At BDI, she has served as the Director of Clinical/Educational Services developing and leading programs for people with diabetes and their families. She developed and led many of BDI’s clinical programs, including “Defeating the Depression/Diabetes Connection” (an intensive, multi-week series), the “Just for Parent’s Program” and “Living Well with Complications” workshop. She also held programs for women with type 1 diabetes, spouses/partners, men with diabetes, and other specialized psycho-educational programs for those with diabetes.

      Dr. Guzman received her PhD in Clinical Psychology with an emphasis in health psychology from the California School of Professional Psychology, San Diego in 1998. She specialized in diabetes following the completion of her post-doctoral fellowship at Scripps Mercy Hospital in San Diego where she served as the psychological liaison to Scripps Health’s Diabetes Advisory Committee.

    FITTER Highlights Day 1

    List of FITTER Highlights Day 1 Sessions:

    Click here to show the FITTER Highlights Day 1 Sessions

    FITTER Highlights Day 2

    List of FITTER Highlights Day 2 Sessions:

    Click here to show the FITTER Highlights Day 2 Sessions

    Recorded Live Sessions Day 1

    List of Recorded Live Sessions Day 1:

    Click here to show the Recorded Live Sessions Day 1

    Recorded Live Sessions Day 2

    List of Recorded Live Sessions Day 2:

    Click here to show the Recorded Live Sessions Day 2

    FITTER attendee interviews

    List of FITTER attendee interviews Sessions:

    Click here to show the FITTER attendee interviews
    Top
    Stay connected